South Korea
South Korea
Explore linked clinical trials.721 results · Page 1 of 29
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Anam | Anam | South Korea | 1 |
| Andong | Andong | South Korea | 1 |
| Andong | Andong | South Korea | 1 |
| Ansan | Ansan | South Korea | 1 |
| Ansan | Ansan | South Korea | 23 |
| Ansan | Ansan | South Korea | 1 |
| Ansan | Ansan | South Korea | 11 |
| Ansan-si | Ansan-si | South Korea | 23 |
| Ansan-si | Ansan-si | South Korea | 17 |
| Ansan-si | Ansan-si | South Korea | 8 |
| Ansan-si | Ansan-si | South Korea | 5 |
| Ansan-si | Ansan-si | South Korea | 4 |
| Ansan-si | Ansan-si | South Korea | 1 |
| Ansan-si Gyenggi-do | Ansan-si Gyenggi-do | South Korea | 1 |
| Ansan-si, Gyeonggi-do | Ansan-si, Gyeonggi-do | South Korea | 2 |
| Anyang | Anyang | South Korea | 23 |
| Anyang | Anyang | South Korea | 1 |
| Anyang | Anyang | South Korea | 1 |
| Anyang-si | Anyang-si | South Korea | 29 |
| Anyang-si | Anyang-si | South Korea | 19 |
| Anyang-si | Anyang-si | South Korea | 2 |
| Anyang-si | Anyang-si | South Korea | 1 |
| Anyang-si | Anyang-si | South Korea | 1 |
| Anyang-si, Gyeonggi-do | Anyang-si, Gyeonggi-do | South Korea | 1 |
| Beon-gil Bundang-gu | Beon-gil Bundang-gu | South Korea | 1 |
3,364 results · Page 1 of 135
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCA | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Not stated | 2026-10-09 | NCT07869602 | |
| Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not applicable | 2026-10-09 | NCT07869238 | |
| Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS Based on the Mobile Application | General Anesthesia; Gynecologic Surgery | Enrolling by invitation | Not applicable | 2026-10-09 | NCT07868952 | |
| Effects of Isometric Wall Squat Training on Blood Pressure in Adults With Hypertension | cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder | Recruiting | Not applicable | 2026-10-09 | NCT07868822 | |
| Predicting Endocrine Resistance Using Molecular Imaging and Liquid Biopsy in Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-10-09 | NCT07867925 | |
| Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke | brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Not yet recruiting | Phase 3 | 2026-10-09 | NCT07730840 | |
| A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis. | Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, scleroderma, skin disorder, systemic sclerosis | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07641634 | |
| Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer | Advanced HR+/HER2- Breast Cancer | Recruiting | Phase 1 | 2026-10-09 | NCT07604571 | |
| A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-10-09 | NCT07554339 | |
| Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD | Multi Vessel Coronary Artery Disease; Percutaneous Coronary Intervention | Recruiting | Not applicable | 2026-10-09 | NCT07539324 | |
| A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) | Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07533006 | |
| First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07529717 | |
| A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-10-09 | NCT07513376 | |
| Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07468071 | |
| Study of INCA036978 in Participants With Myeloproliferative Neoplasms | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, neoplasm, primary myelofibrosis, thrombocytosis disease | Recruiting | Phase 1 | 2026-10-09 | NCT07441694 | |
| A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies | Solid Tumors | Recruiting | Phase 2 | 2026-10-09 | NCT07415031 | |
| A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Phase 3 | 2026-10-09 | NCT07357727 | |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07284849 | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 2 | 2026-10-09 | NCT07284459 | |
| A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) | Small Cell Lung Cancer Extensive Stage | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07227597 | |
| AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL | large B-cell lymphoma | Recruiting | Phase 3 | 2026-10-09 | NCT07215585 | |
| Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 3 | 2026-10-09 | NCT07214779 | |
| Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 3 | 2026-10-09 | NCT07177352 | |
| A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | Advanced Solid Cancer; Advanced Solid Tumor (Phase 1) | Recruiting | Phase 1 | 2026-10-09 | NCT07123415 | |
| Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-10-09 | NCT07100080 |